Tucker Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$123K Buy
+597
New +$112K 0.04% 168
2025
Q2
Sell
-1,649
Closed -$227K 301
2025
Q1
$227K Sell
1,649
-210
-11% -$26.8K 0.07% 78
2024
Q4
$220K Sell
1,859
-478
-20% -$55.8K 0.02% 126
2024
Q3
$258K Sell
2,337
-842
-26% -$88K 0.06% 118
2024
Q2
$313K Sell
3,179
-641
-17% -$65.3K 0.07% 110
2024
Q1
$427K Sell
3,820
-1,963
-34% -$212K 0.1% 73
2023
Q4
$583K Sell
5,783
-694
-11% -$68.9K 0.15% 49
2023
Q3
$562K Buy
6,477
+2,268
+54% +$205K 0.15% 47
2023
Q2
$398K Buy
4,209
+3,395
+417% +$287K 0.12% 45
2023
Q1
$61.5K Buy
814
+633
+350% +$47.8K 0.02% 219
2022
Q4
$14.1K Buy
+181
New +$13.8K ﹤0.01% 295
2021
Q1
Sell
-16
Closed -$857 344
2020
Q4
$857 Buy
+16
New +$830 ﹤0.01% 337

Other funds holding CAH

Tucker Asset Management's CAH Position: Q4 2025 in Review

Tucker Asset Management opened a new position in Cardinal Health (CAH) in Q4 2025: 597 shares worth $123K. The stake represents 0.04% of the portfolio and ranks #168 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in CAH as recently as Q1 2025.

Tucker Asset Management first reported a position in CAH in Q4 2020 and has held it in 12 quarters since. The position peaked at $583K in Q4 2023. 1,405 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Tucker Asset Management held 597 shares of Cardinal Health worth $123K as of Q4 2025.
  • Cardinal Health was a new Tucker Asset Management position in Q4 2025.
  • Cardinal Health made up 0.04% of Tucker Asset Management's portfolio in Q4 2025, its #168 holding.
  • Tucker Asset Management first reported a position in Cardinal Health in Q4 2020 and has held it in 12 quarters since.
  • Tucker Asset Management's Cardinal Health position peaked at $583K in Q4 2023.
  • 1,405 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.